BTKI

Clinical trials for BTKI explained in plain language.

Never miss a new study

Get alerted when new BTKI trials appear

Sign up with your email to follow new studies for BTKI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for aggressive blood cancer: targeted combo shows promise

Disease control Recruiting now

This study is for people with a newly diagnosed, aggressive type of blood cancer called mantle cell lymphoma (MCL). Researchers want to see if adding a drug called glofitamab after initial treatment with a BTK inhibitor and rituximab can better control the disease. About 30 parti…

Matched conditions: BTKI

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Apr 30, 2026 15:49 UTC

BTKI

Get alerted when new BTKI trials appear

New hope for aggressive blood cancer: targeted combo shows promise